Xilio Therapeutics, Inc.
Institutional holders · 13F as of Jun 30, 2026
| Holder | Value | % of shares |
|---|---|---|
| Merck & Co., Inc. | $1.02M | 1.83% |
| Renaissance Technologies LLC | $416.9K | 0.86% |
| GEODE CAPITAL MANAGEMENT, LLC | $312.8K | 0.64% |
| STATE STREET CORPORATION | $127.5K | 0.23% |
| BlackRock, Inc. | $83.9K | 0.15% |
| Royal Bank of Canada | $1.0K | 0.00% |
| GSA CAPITAL PARTNERS LLP | $143 | 0.29% |